What is it about?
With great interest, we read the very recent article of Anna Lidia Wojdala and colleagues (2023,in press) and would like to comment on this important paper.
Featured Image
Read the Original
This page is a summary of: Blood plasma biomarkers for Alzheimer’s disease: Aβ1–42/1–40 vs. AβX–42/X–40, Clinical Chemistry and Laboratory Medicine (CCLM), October 2023, De Gruyter,
DOI: 10.1515/cclm-2023-0990.
You can read the full text:
Contributors
The following have contributed to this page
